CD134: The EpiPen Hearing

Congressional Dish

Jennifer Briney

News, Congress, Government, Politics, Corporations

4.8 • 1.1K Ratings

🗓️ 25 September 2016

⏱️ 69 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Epinephrine injectors are life saving devices for people with food allergies and one company - Mylan Inc. - produces almost all of them. In this episode, listen to the highlights from a House Oversight and Government Reform Committee grilling of Mylan CEO Heather Bresch, and judge her justification for raising the EpiPen's price over 600% since EpiPen's competition was eliminated. Executive Producer: Anonymous Please support Congressional Dish: to contribute with PayPal or Bitcoin; click the PayPal "Make it Monthly" checkbox to create a monthly subscription to support Congressional Dish for each episode via Patreon Mail Contributions to: 5753 Hwy 85 North #4576 Crestview, FL 32536 Thank you for supporting truly independent media! Sound Clip Sources Hearing: House Oversight and Government Reform Committee, September 21, 2016. Witnesses , CEO of Mylan Inc. , Deputy Center Director for Regulatory Programs Clip Timestamps (In order of appearance in episode) 51:16 - Doug Throckmorton: Available epinephrine injectors 49:55 - Rep. John Mica (FL) and Doug Throckmorton: FDA won't discuss generic applications 0:35 - Chairman Jason Chaffetz (UT) - Introduction 9:25 - Elijah Cummings (MD): Mylan's actions that Congress is investigating 12:20 - Elijah Cummings: List of EpiPen price increases 4:10 - Jason Chaffetz: Executive compensation 16:55 - Elijah Cummings: Martin Shkreli called Congress "imbeciles" 24:10 - Heather Bresch: Introduction 28:16 - Heather Bresch: Mylan's profits from each EpiPen 47:43 - Rep. Elijah Cummings (MD) & Heather Bresch: Mylan did not give Congress requested documents 55:10 - Rep. Eleanor Holmes Norton & Heather Bresch: Will Mylan reduce the price of EpiPens? 1:23:26 - Rep. Scott DesJarlais (TN) & Heather Bresch: How long were the price increases going to continue? 1:32:10 - Rep. Gerald Connolly (VA) & Heather Bresch: Mylan's EpiPen is 94% of the epinephrine injector market. 1:56:55 - Rep. Stacey Plaskett (VI) & Heather Bresch: Why are customers paying so much for EpiPens? 2:01:04 - Rep. Mark Meadows (NC) & Heather Bresch: Everyone pays a different price in this system 2:51:15 - Rep. Bonnie Watson Coleman (NJ) & Heather Bresch: Mylan moved their headquarters to the Netherlands to pay less in U.S. taxes. 2:37:15 - Rep. Peter Welch & Heather Bresch: EpiPens cost much less in the Netherlands 1:03:15 - Rep. John Duncan (TN): Drug companies have manipulated the market. 1:44:25 - Tammy Duckworth (IL) & Heather Bresch: Mylan prohibited schools from buying from competitors 36:45 - Rep. Jason Chaffetz (UT) & Heather Bresch: Heather Bresch's explanation for why her mother used her position to get schools to buy EpiPens from Mylan 1:11:40 - Rep. Tim Walberg (MI) & Heather Bresch: Mylans plan would shift costs of EpiPens to government 1:21:16 - Rep. Stephen Lynch (MA) & Heather Bresch: Veterans Administration is able to negotiate it's drug prices, which makes them lower 53:35 - Rep. John Mica (FL) & Heather Bresch: Executive compensation at Mylan 59:19 - Rep. Eleanor Holmes Norton (DC) & Heather Bresch: What does Heather Bresch do to earn $18 million per year? 2:48:55 - Rep. Bonnie Watson Coleman (NJ) & Heather Bresch: Heather Bresch often uses a company private jet 2:13:50 - Rep. Mick Mulvaney (SC) & Heather Bresch: Mylan is getting what it deserves 3:08:08 - Rep. Glenn Grothman (WI) & Heather Bresch: Does Heather Bresch feel guilty? 3:39:40 - Rep. Jason Chaffetz & Heather Bresch: The numbers don't add up. 3:43:30 - Rep. Elijah Cummings (MD) Closing statement Additional Reading Article: by Jayne O'Donnell, USA Today, September 21, 2016. Article: by Olga Khazan, The Atlantic, August 24, 2016. Article: by Kelefa Sanneh, The New Yorker, February 5, 2016. Additional Information Law: OpenSecrets: Music Presented in This Episode Intro & Exit: by (found on by mevio) Cover Art Design by

Transcript

Click on a timestamp to play from that location

0:00.0	I am so damn tired of being like to.
0:09.0	I don't think I can't deny it anymore.
0:15.0	You can stick to your story if you think it flies.
0:24.0	but I'm not gonna buy it anymore.
0:30.0	Hello and thank you for tuning into the 134th episode of Congressional dish.
0:35.0	I'm your host Jennifer Braney.
0:37.0	So I'm guessing that quite a few of you are expecting to turn on Congressional dish today
0:42.0	and hear about the Every Student Succeed Act, which was a major education overhaul that was signed into law back in December, but at the same time as some other very large pieces of legislation that I just haven't gotten to yet.
0:54.8	So we need to know about this education bill before we vote and I'm working on it.
0:58.8	The thing is that this is a really hard episode to do.
1:02.0	I've finished reading the bill and now I just need a few extra days for the research because what I originally saw as a pretty mundane bill. I'm actually the more that I'm researching and
1:15.1	looking into the background of it I'm thinking it's much more significant than
1:18.1	I thought before so I really want to make sure that I get all the information into
1:21.8	this one and really understand the intent behind the
1:25.3	Every Student Succeed Act and I think that picture is starting to come together in my head and so basically by waiting
1:31.1	you guys are going to get a better episode but I do
1:33.2	apologize for the delay on that. What I'm going to do is I'll be releasing
1:36.6	that next Sunday assuming that my sister does not have a baby in between now and
1:40.7	then because I'm getting on a flight tonight to go down to Los Angeles
1:45.2	where I'm basically hanging out with my sister until she pops.
1:50.0	So assuming that she stays until a little bit closer to her due date, she's not due until
1:55.2	October 9th, but if she has a baby next week, that's just about the only thing that can
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Jennifer Briney, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Jennifer Briney and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.